| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $11.2M | — | +49.9% |
| SG&A Expense | $3.7M | — | +49.9% |
| Operating Income | -$14.9M | — | -49.9% |
| Pre-tax Income | -$13.1M | — | -183.2% |
| Income Tax | $0 | — | — |
| Net Income | -$13.7M | — | -190.1% |
| EPS (Basic) | -$0.15 | — | -171.4% |
| EPS (Diluted) | -$0.15 | — | -15.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $40.1M | +776.4% | +702.2% |
| Accounts Receivable | $43K | +16.2% | -45.6% |
| Current Assets | $239.9M | +312.2% | +427.5% |
| Total Assets | $253.2M | +256.0% | +326.0% |
| Current Liabilities | $12.1M | +29.1% | +30.5% |
| Total Liabilities | $12.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.4M | — | -25.5% |
| Capital Expenditures | $91K | — | +152.8% |
| Investing Cash Flow | -$144.8M | — | -3513.8% |
| Financing Cash Flow | $190.7M | — | — |
| Free Cash Flow | -$10.5M | — | -26.1% |
| +23.8% |
| Stockholders' Equity | $240.7M | +293.2% | +387.9% |